Showing results (41-50 of 261) with videos related to

Sort By:
Pageof 27
ANZ Journal of Surgery|April 25, 2018
Model predicting the microvascular invasion and satellite lesions of hepatocellular carcinoma after hepatectomyJunyi Shen, Tianfu Wen, Weixia Chen, et al.
Digestive Diseases (Basel, Switzerland)|April 20, 2018
The Prognostic Prediction Role of Preoperative Serum Albumin Level in Patients with Intahepatic Cholangiocarcinoma Following HepatectomyJunyi Shen, Tianfu Wen, Chuan Li, et al.
The Journal of Surgical Research|August 17, 2015
Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?Jiwei Huang, Lunan Yan, Hong Wu, et al.
BMC Surgery|April 28, 2023
A new method for predicting the microvascular invasion status of hepatocellular carcinoma through neural network analysisJinli Zheng, Xiaozhen Wei, Ning Wang, et al.
Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology|October 29, 2025
[Evaluation on the expression efficiency of personalized labial appliances in non-extraction orthodontic treatment for mild crowding of teeth]Xiaoyan Mao, Le Huang, Jiayin Yang, et al.
Surgical Endoscopy|July 8, 2025
Integration of near-infrared fluorescence imaging and Sonazoid contrast-enhanced ultrasound in laparoscopic resection of colorectal liver metastases: a dual-center retrospective studyJiaguo Wang, Jie Xu, Jingsheng Yuan, et al.
Cell Communication and Signaling : CCS|August 8, 2022
Cellular crosstalk during liver regeneration: unity in diversityWenzhi Shu, Mengfan Yang, Jiayin Yang, et al.
Cancer Research and Treatment|June 19, 2019
WITHDRAWN:PPARα Suppresses PD-L1-Mediated Immune Escape by Down-regulating SPP1 in Human Hepatocellular CarcinomaGuoliang Wang, Yan Liu, Jianzhao Huang, et al.
BMC Cancer|March 24, 2022
A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort studyYong Zhao, Ling Xiang Kong, Feng Shi Feng, et al.
Frontiers in Immunology|October 24, 2022
A novel medication decision gene signature predicts response to individualized therapy and prognosis outcomes in hepatocellular carcinoma patientsJingsheng Yuan, Zijian Liu, Zhenru Wu, et al.
Pageof 27